Evaluation of connectivity map shows limited reproducibility in drug repositioning
Abstract The Connectivity Map (CMap) is a popular resource designed for data-driven drug repositioning using a large transcriptomic compendium. However, evaluations of its performance are limited. We used two iterations of CMap (CMap 1 and 2) to assess their comparability and reliability. We queried...
Enregistré dans:
Auteurs principaux: | Nathaniel Lim, Paul Pavlidis |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/9e2c9782c48e4f3c8dd4b0ba6b14221c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Enriching limited information on rare diseases from heterogeneous networks for drug repositioning
par: Hongkui Cao, et autres
Publié: (2021) -
Drug repositioning of Clopidogrel or Triamterene to inhibit influenza virus replication in vitro.
par: Nichole Orr-Burks, et autres
Publié: (2021) -
Drug repositioning by merging active subnetworks validated in cancer and COVID-19
par: Marta Lucchetta, et autres
Publié: (2021) -
Transcriptional drug repositioning and cheminformatics approach for differentiation therapy of leukaemia cells
par: Yasaman KalantarMotamedi, et autres
Publié: (2021) -
Drug repositioning of Clopidogrel or Triamterene to inhibit influenza virus replication in vitro
par: Nichole Orr-Burks, et autres
Publié: (2021)